Company Financials

Kymera Therapeutics, Inc. Financials

United States dollar

business Kymera Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: KYMR

Market Capitalization $5.82 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -24.42
Forward PE -19.63
Price to Sales TTM $133.09
Price to Book MRQ $5.52
Enterprise to Revenue 110.06
Enterprise to EBITDA -14.97

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin -3207.89%
Return on Assets TTM -19.21%
Return on Equity TTM -32.09%

Income Statement

Revenue TTM $43,735,000
Revenue per Share TTM $0.53
Quarterly Revenue Growth -26.10%
Gross Profit TTM $-260,819,008
EBITDA $-321,535,008
Net Income to Common TTM $-295,121,984
Diluted EPS TTM $-3.60
Quarterly Earnings Growth YoY -26.12%

Balance Sheet

Total Cash MRQ $505,681,984
Total Cash per Share MRQ $7.03
Total Debt MRQ $
Total Debt to Equity MRQ 8.88
Current Ratio MRQ 7.38
Book Value per Share MRQ $13.19

Cash Flow

Operating Cash Flow TTM $-227,928,000
Levered Free Cash Flow TTM $-139,944,752

KYMR Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 71,741,174
Float Shares 48,455,511
Avg 10 Volume 757,750
Avg 30 Volume None
Shares Short 7,894,340
Short Ratio 5.76
Short % of Shares 11.88%
% Held by Insiders 2.25%
% Held by Institutions 106.85%

Stock Price Summary

Beta 2.29
Fifty Two Week Low $19.45
Fifty Two Week High $103.00
Fifty Two Week Change 45.16%
Day 50 MA $70.13
Day 200 MA $48.30

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date